NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

35 hedge funds and large institutions have $31.1M invested in NeuBase Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$32K
Puts
$93K
Net Calls
Net Calls Change

Top Buyers

1
+$12.2M
2
+$3.69M
3
+$2.23M
4
U
UBS
Switzerland
+$908K
5
BIM
Bogle Investment Management
Massachusetts
+$880K

Top Sellers

1
-$28K
2
-$27K
3
-$10.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$12.2M
2
$4.6M
3
$2.23M
4
$1.84M
5
$1.12M
6
$935K
7
$880K
8
$785K
9
$759K
10
$663K
11
$658K
12
$543K
13
$470K
14
$419K
15
$396K
16
$392K
17
$322K
18
$250K
19
$186K
20
$178K
21
$176K
22
$168K
23
$167K
24
$158K
25
$152K
1
2